GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Deferred Tax

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Deferred Tax : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Anhui Anke Biotechnology (Group) Co's change in deferred tax for the three months ended in Mar. 2025 was ¥0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0 Mil.

Anhui Anke Biotechnology (Group) Co Deferred Tax Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co Deferred Tax Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Anhui Anke Biotechnology (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Anhui Anke Biotechnology (Group) Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anhui Anke Biotechnology (Group) Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Anke Biotechnology (Group) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Deferred Tax
Comparable Companies
SZSE:300294 SHSE:688382 SZSE:002287 SHSE:600866 SHSE:688068 SHSE:688076 SZSE:000403 SHSE:688520 SHSE:688739 SHSE:600645 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Website
http://www.ankebio.com
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
Executives
Zhao Hui Directors, executives
Zhou Yuan Yuan Directors, executives
Wang Yong Supervisors
Yao Jian Ping Executives
Wang Rong Hai Directors, executives
Song She Wu Directors, executives
Fu Yong Biao Directors, executives
Jiang Jun Pei Supervisors
Xu Zhen Shan Director
Lu Guang Xin Executives
Yan Xin Wen Executives
Lu Chun Yan Executives
Wu Rui Director
Fan Qing Lin Director
Wang Yong Bin Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines